<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38156008</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Development and management of gastrointestinal symptoms in long-term COVID-19.</ArticleTitle><Pagination><StartPage>1278479</StartPage><MedlinePgn>1278479</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1278479</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2023.1278479</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Emerging evidence reveals that SARS-CoV-2 possesses the capability to disrupt the gastrointestinal (GI) homeostasis, resulting in the long-term symptoms such as loss of appetite, diarrhea, gastroesophageal reflux, and nausea. In the current review, we summarized recent reports regarding the long-term effects of COVID-19 (long COVID) on the gastrointestine.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To provide a narrative review of abundant clinical evidence regarding the development and management of long-term GI symptoms in COVID-19 patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Long-term persistent digestive symptoms are exhibited in a majority of long-COVID patients. SARS-CoV-2 infection of intestinal epithelial cells, cytokine storm, gut dysbiosis, therapeutic drugs, psychological factors and exacerbation of primary underlying diseases lead to long-term GI symptoms in COVID-19 patients. Interventions like probiotics, prebiotics, fecal microbiota transplantation, and antibiotics are proved to be beneficial in preserving intestinal microecological homeostasis and alleviating GI symptoms.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Timely diagnosis and treatment of GI symptoms in long-COVID patients hold great significance as they may contribute to the mitigation of severe conditions and ultimately lead to the improvement of outcomes of the patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 He, Lei, Zhang, Wu, Li, Lu, Laila, Cui, Xu and Jian.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>He</LastName><ForeName>Kai-Yue</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Henan University, Kaifeng, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lei</LastName><ForeName>Xin-Yuan</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Henan University, Kaifeng, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Henan University, Kaifeng, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Dan-Hui</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Henan University, Kaifeng, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jun-Qi</ForeName><Initials>JQ</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Henan University, Kaifeng, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Li-Yuan</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Henan University, Kaifeng, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laila</LastName><ForeName>Umm E</ForeName><Initials>UE</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Henan University, Kaifeng, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Cui-Yun</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Blood Transfusion, Henan Provincial People's Hospital, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Zhi-Xiang</ForeName><Initials>ZX</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Henan University, Kaifeng, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jian</LastName><ForeName>Yong-Ping</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Henan University, Kaifeng, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">gastrointestinal symptoms</Keyword><Keyword MajorTopicYN="N">gut microbiota</Keyword><Keyword MajorTopicYN="N">immune responses</Keyword><Keyword MajorTopicYN="N">long-term effects of COVID-19 (long-COVID)</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword><Keyword MajorTopicYN="N">therapeutics</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>2</Day><Hour>10</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>2</Day><Hour>10</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>29</Day><Hour>3</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38156008</ArticleId><ArticleId IdType="pmc">PMC10752947</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2023.1278479</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Afrisham R., Jadidi Y., Davoudi M., Moayedi K., Soliemanifar O., Eleni Xirouchaki C., et al. (2023). Gastrointestinal, liver, pancreas, oral and psychological long-term symptoms of COVID-19 after recovery: a review. Mini Rev. Med. Chem. 23 852&#x2013;868. 10.2174/1389557523666221116154907</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389557523666221116154907</ArticleId><ArticleId IdType="pubmed">36397624</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O. L., Hughes S. E., Turner G., Rivera S. C., Mcmullan C., Chandan J. S., et al. (2021). Symptoms, complications and management of long COVID: a review. J. R. Soc. Med. 114 428&#x2013;442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Bataineh M. T., Henschel A., Mousa M., Daou M., Waasia F., Kannout H., et al. (2021). Gut microbiota interplay With COVID-19 reveals links to host lipid metabolism among middle eastern populations. Front. Microbiol. 12:761067. 10.3389/fmicb.2021.761067</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.761067</ArticleId><ArticleId IdType="pmc">PMC8603808</ArticleId><ArticleId IdType="pubmed">34803986</ArticleId></ArticleIdList></Reference><Reference><Citation>Albrich W. C., Ghosh T. S., Ahearn-Ford S., Mikaeloff F., Lunjani N., Forde B., et al. (2022). A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2. Gut Microbes 14:2073131. 10.1080/19490976.2022.2073131</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2022.2073131</ArticleId><ArticleId IdType="pmc">PMC9116414</ArticleId><ArticleId IdType="pubmed">35574937</ArticleId></ArticleIdList></Reference><Reference><Citation>Amarsy R., Trystram D., Cambau E., Monteil C., Fournier S., Oliary J., et al. (2022). Surging bloodstream infections and antimicrobial resistance during the first wave of COVID-19: a study in a large multihospital institution in the Paris region. Int. J. Infect. Dis. 114 90&#x2013;96. 10.1016/j.ijid.2021.10.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.10.034</ArticleId><ArticleId IdType="pmc">PMC8531236</ArticleId><ArticleId IdType="pubmed">34688945</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin-Chowdhury Z., Aiano F., Mensah A., Sheppard C. L., Litt D., Fry N. K., et al. (2021). Impact of the coronavirus disease 2019 (COVID-19) pandemic on invasive pneumococcal disease and risk of pneumococcal coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): prospective national cohort study, England. Clin. Infect. Dis. 72 e65&#x2013;e75. 10.1093/cid/ciaa1728</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1728</ArticleId><ArticleId IdType="pmc">PMC7717180</ArticleId><ArticleId IdType="pubmed">33196783</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya J. M., Rojas M., Salinas M. L., Rodr&#xed;guez Y., Roa G., Lozano M., et al. (2021). Post-COVID syndrome. A case series and comprehensive review. Autoimmun. Rev. 20:102947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Antunes K. H., Fachi J. L., De Paula R., Da Silva E. F., Pral L. P., Dos Santos A., et al. (2019). Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response. Nat. Commun. 10:3273. 10.1038/s41467-019-11152-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11152-6</ArticleId><ArticleId IdType="pmc">PMC6646332</ArticleId><ArticleId IdType="pubmed">31332169</ArticleId></ArticleIdList></Reference><Reference><Citation>Au L., Fendler A., Shepherd S. T. C., Rzeniewicz K., Cerrone M., Byrne F., et al. (2021). Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2. Nat. Med. 27 1362&#x2013;1366. 10.1038/s41591-021-01387-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01387-6</ArticleId><ArticleId IdType="pmc">PMC8363501</ArticleId><ArticleId IdType="pubmed">34040262</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz M., Fatima R., Assaly R. (2020). Elevated interleukin-6 and severe COVID-19: a meta-analysis. J. Med. Virol. 92 2283&#x2013;2285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267383</ArticleId><ArticleId IdType="pubmed">32343429</ArticleId></ArticleIdList></Reference><Reference><Citation>Badgeley A., Anwar H., Modi K., Murphy P., Lakshmikuttyamma A. (2021). Effect of probiotics and gut microbiota on anti-cancer drugs: mechanistic perspectives. Biochim. Biophys. Acta Rev. Cancer 1875:188494. 10.1016/j.bbcan.2020.188494</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbcan.2020.188494</ArticleId><ArticleId IdType="pubmed">33346129</ArticleId></ArticleIdList></Reference><Reference><Citation>Balasubramaniam A., Tedbury P. R., Mwangi S. M., Liu Y., Li G., Merlin D., et al. (2023). SARS-CoV-2 induces epithelial-enteric neuronal crosstalk stimulating VIP release. Biomolecules 13:207. 10.3390/biom13020207</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom13020207</ArticleId><ArticleId IdType="pmc">PMC9953368</ArticleId><ArticleId IdType="pubmed">36830577</ArticleId></ArticleIdList></Reference><Reference><Citation>Baroni C., Potito J., Perticone M. E., Orausclio P., Luna C. M. (2023). How does long-COVID impact prognosis and the long-term sequelae? Viruses 15:1173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10222218</ArticleId><ArticleId IdType="pubmed">37243259</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassey E. E., Gupta A., Kapoor A., Bansal A. (2023). COVID-19 and poverty in South America: the mental health implications. Int. J. Ment. Health Addict. 21, 2954&#x2013;2960. 10.1007/s11469-022-00765-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11469-022-00765-6</ArticleId><ArticleId IdType="pmc">PMC8785692</ArticleId><ArticleId IdType="pubmed">35095354</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard-Raichon L., Venzon M., Klein J., Axelrad J. E., Zhang C., Sullivan A. P., et al. (2022). Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia. Nat. Commun. 13:5926. 10.1038/s41467-022-33395-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33395-6</ArticleId><ArticleId IdType="pmc">PMC9626559</ArticleId><ArticleId IdType="pubmed">36319618</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezzio C., Saibeni S., Variola A., Allocca M., Massari A., Gerardi V., et al. (2020). Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut 69 1213&#x2013;1217. 10.1136/gutjnl-2020-321411</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-321411</ArticleId><ArticleId IdType="pubmed">32354990</ArticleId></ArticleIdList></Reference><Reference><Citation>Bili&#x144;ski J., Winter K., Jasi&#x144;ski M., Szcz&#x229;&#x15b; A., Bilinska N., Mullish B. H., et al. (2022). Rapid resolution of COVID-19 after faecal microbiota transplantation. Gut 71, 230&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">34230217</ArticleId></ArticleIdList></Reference><Reference><Citation>Boicean A., Neamtu B., Birsan S., Batar F., Tanasescu C., Dura H., et al. (2022). Fecal microbiota transplantation in patients co-infected with SARS-CoV2 and Clostridioides difficile. Biomedicines 11:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9855959</ArticleId><ArticleId IdType="pubmed">36672518</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J., Wang C., Zhang Y., Lei G., Xu K., Zhao N., et al. (2021). Integrated gut virome and bacteriome dynamics in COVID-19 patients. Gut Microbes 13, 1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7946006</ArticleId><ArticleId IdType="pubmed">33678150</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. (2020). Persistent symptoms in patients after acute COVID-19. JAMA 324 603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., et al. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395 507&#x2013;513. 10.1016/S0140-6736(20)30211-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R. R., Li Y. J., Chen J. J., Lu C. L. (2020). A review for natural polysaccharides with anti-pulmonary fibrosis properties, which may benefit to patients infected by 2019-nCoV. Carbohydr. Polym. 247:116740. 10.1016/j.carbpol.2020.116740</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carbpol.2020.116740</ArticleId><ArticleId IdType="pmc">PMC7340049</ArticleId><ArticleId IdType="pubmed">32829859</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Han W., Wang G., Zhao X. (2020). Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines. Int. J. Biol. Macromol. 164 331&#x2013;343. 10.1016/j.ijbiomac.2020.07.106</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2020.07.106</ArticleId><ArticleId IdType="pmc">PMC7358770</ArticleId><ArticleId IdType="pubmed">32679328</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Chen L., Deng Q., Zhang G., Wu K., Ni L., et al. (2020). The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J. Med. Virol. 92 833&#x2013;840.</Citation><ArticleIdList><ArticleId IdType="pubmed">32243607</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng S., Ma X., Geng S., Jiang X., Li Y., Hu L., et al. (2018). Fecal microbiota transplantation beneficially regulates intestinal mucosal autophagy and alleviates gut barrier injury. mSystems 3:e00137&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6178585</ArticleId><ArticleId IdType="pubmed">30320222</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung K. S., Hung I. F. N., Chan P. P. Y., Lung K. C., Tso E., Liu R., et al. (2020). Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology 159 81&#x2013;95. 10.1053/j.gastro.2020.03.065</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.03.065</ArticleId><ArticleId IdType="pmc">PMC7194936</ArticleId><ArticleId IdType="pubmed">32251668</ArticleId></ArticleIdList></Reference><Reference><Citation>Chitapanarux I., Chitapanarux T., Traisathit P., Kudumpee S., Tharavichitkul E., Lorvidhaya V. (2010). Randomized controlled trial of live Lactobacillus acidophilus plus Bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat. Oncol. 5:31. 10.1186/1748-717X-5-31</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1748-717X-5-31</ArticleId><ArticleId IdType="pmc">PMC2874795</ArticleId><ArticleId IdType="pubmed">20444243</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerbaux L. A., Fillipovska J., Mu&#xf1;oz A., Petrillo M., Coecke S., Amorim M. J., et al. (2022). Mechanisms leading to gut dysbiosis in COVID-19: current evidence and uncertainties based on adverse outcome pathways. J. Clin. Med. 11:5400. 10.3390/jcm11185400</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11185400</ArticleId><ArticleId IdType="pmc">PMC9505288</ArticleId><ArticleId IdType="pubmed">36143044</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes G. M., Marcialis M. A., Bardanzellu F., Corrias A., Fanos V., Mussap M. (2022). Inflammatory bowel disease and COVID-19: how microbiomics and metabolomics depict two sides of the same coin. Front. Microbiol. 13:856165. 10.3389/fmicb.2022.856165</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.856165</ArticleId><ArticleId IdType="pmc">PMC8981987</ArticleId><ArticleId IdType="pubmed">35391730</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico F., Baumgart D. C., Danese S., Peyrin-Biroulet L. (2020). Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management. Clin. Gastroenterol. Hepatol. 18 1663&#x2013;1672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7141637</ArticleId><ArticleId IdType="pubmed">32278065</ArticleId></ArticleIdList></Reference><Reference><Citation>d&#x2019;Ettorre G., Ceccarelli G., Marazzato M., Campagna G., Pinacchio C., Alessandri F., et al. (2020). Challenges in the management of SARS-CoV2 infection: the role of oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of COVID-19. Front. Med. (Lausanne) 7:389. 10.3389/fmed.2020.00389</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00389</ArticleId><ArticleId IdType="pmc">PMC7358304</ArticleId><ArticleId IdType="pubmed">32733907</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang A. T., Marsland B. J. (2019). Microbes, metabolites, and the gut-lung axis. Mucosal Immunol. 12 843&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pubmed">30976087</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong S. E., Olin A., Pulendran B. (2020). The impact of the microbiome on immunity to vaccination in humans. Cell Host Microbe 28 169&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7422826</ArticleId><ArticleId IdType="pubmed">32791110</ArticleId></ArticleIdList></Reference><Reference><Citation>De Maio F., Ianiro G., Coppola G., Santopaolo F., Abbate V., Bianco D. M., et al. (2021). Improved gut microbiota features after the resolution of SARS-CoV-2 infection. Gut Pathog. 13:62. 10.1186/s13099-021-00459-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13099-021-00459-9</ArticleId><ArticleId IdType="pmc">PMC8520333</ArticleId><ArticleId IdType="pubmed">34656179</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng W., Xu Y., Kong Q., Xue J., Yu P., Liu J., et al. (2020). Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo. Signal Transduct. Target. Ther. 5:66. 10.1038/s41392-020-0176-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-0176-0</ArticleId><ArticleId IdType="pmc">PMC7205908</ArticleId><ArticleId IdType="pubmed">32385228</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhar D., Mohanty A. (2020). Gut microbiota and Covid-19- possible link and implications. Virus Res. 285:198018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7217790</ArticleId><ArticleId IdType="pubmed">32430279</ArticleId></ArticleIdList></Reference><Reference><Citation>Doubravsk&#xe1; L., Htoutou Sedl&#xe1;kov&#xe1; M., Fi&#x161;erov&#xe1; K., Pudov&#xe1; V., Urb&#xe1;nek K., Petr&#x17e;elov&#xe1; J., et al. (2022). Bacterial resistance to antibiotics and clonal spread in COVID-19-positive patients on a tertiary hospital intensive care unit, Czech Republic. Antibiotics (Basel) 11:783. 10.3390/antibiotics11060783</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics11060783</ArticleId><ArticleId IdType="pmc">PMC9219711</ArticleId><ArticleId IdType="pubmed">35740188</ArticleId></ArticleIdList></Reference><Reference><Citation>Du M., Cai G., Chen F., Christiani D. C., Zhang Z., Wang M. (2020). Multiomics evaluation of gastrointestinal and other clinical characteristics of COVID-19. Gastroenterology 158 2298&#x2013;2301.e2297. 10.1053/j.gastro.2020.03.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.03.045</ArticleId><ArticleId IdType="pmc">PMC7270476</ArticleId><ArticleId IdType="pubmed">32234303</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimzadeh A., Taghizadeh M., Milajerdi A. (2022). Major dietary patterns in relation to disease severity, symptoms, and inflammatory markers in patients recovered from COVID-19. Front. Nutr. 9:929384. 10.3389/fnut.2022.929384</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.929384</ArticleId><ArticleId IdType="pmc">PMC9446542</ArticleId><ArticleId IdType="pubmed">36082030</ArticleId></ArticleIdList></Reference><Reference><Citation>Effenberger M., Grabherr F., Mayr L., Schwaerzler J., Nairz M., Seifert M., et al. (2020). Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut 69 1543&#x2013;1544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211078</ArticleId><ArticleId IdType="pubmed">32312790</ArticleId></ArticleIdList></Reference><Reference><Citation>Eiseman B., Silen W., Bascom G. S., Kauvar A. J. (1958). Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44, 854&#x2013;859.</Citation><ArticleIdList><ArticleId IdType="pubmed">13592638</ArticleId></ArticleIdList></Reference><Reference><Citation>El Hajra Mart&#xed;nez I., Relea P&#xe9;rez L., Calvo Moya M. (2020). Presence of SARS-coronavirus-2 in the ileal mucosa: another evidence for infection of GI tract by this virus. Gastroenterology 159 1624&#x2013;1625. 10.1053/j.gastro.2020.05.101</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.101</ArticleId><ArticleId IdType="pmc">PMC7411422</ArticleId><ArticleId IdType="pubmed">32777284</ArticleId></ArticleIdList></Reference><Reference><Citation>Everitt H. A., Landau S., O&#x2019;reilly G., Sibelli A., Hughes S., Windgassen S., et al. (2019). Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial. Lancet Gastroenterol. Hepatol. 4 863&#x2013;872. 10.1016/S2468-1253(19)30243-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(19)30243-2</ArticleId><ArticleId IdType="pmc">PMC7026694</ArticleId><ArticleId IdType="pubmed">31492643</ArticleId></ArticleIdList></Reference><Reference><Citation>Faghfouri A. H., Baradaran B., Khabbazi A., Khaje Bishak Y., Zarezadeh M., Tavakoli-Rouzbehani O. M., et al. (2021). Profiling inflammatory cytokines following zinc supplementation: a systematic review and meta-analysis of controlled trials. Br. J. Nutr. 126 1441&#x2013;1450.</Citation><ArticleIdList><ArticleId IdType="pubmed">33468279</ArticleId></ArticleIdList></Reference><Reference><Citation>Faghfouri A. H., Zarrin R., Maleki V., Payahoo L., Khajebishak Y. (2020). A comprehensive mechanistic review insight into the effects of micronutrients on toll-like receptors functions. Pharmacol. Res. 152:104619. 10.1016/j.phrs.2019.104619</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2019.104619</ArticleId><ArticleId IdType="pubmed">31887355</ArticleId></ArticleIdList></Reference><Reference><Citation>Faresj&#xf6; A., Grodzinsky E., Johansson S., Wallander M. A., Timpka T., Akerlind I. (2007). Psychosocial factors at work and in every day life are associated with irritable bowel syndrome. Eur. J. Epidemiol. 22 473&#x2013;480. 10.1007/s10654-007-9133-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-007-9133-2</ArticleId><ArticleId IdType="pubmed">17484023</ArticleId></ArticleIdList></Reference><Reference><Citation>Farsi Y., Tahvildari A., Arbabi M., Vazife F., Sechi L. A., Shahidi Bonjar A. H., et al. (2022). Diagnostic, prognostic, and therapeutic roles of gut microbiota in COVID-19: a comprehensive systematic review. Front. Cell. Infect. Microbiol. 12:804644. 10.3389/fcimb.2022.804644</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.804644</ArticleId><ArticleId IdType="pmc">PMC8930898</ArticleId><ArticleId IdType="pubmed">35310853</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasano A. (2011). Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol. Rev. 91 151&#x2013;175. 10.1152/physrev.00003.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00003.2008</ArticleId><ArticleId IdType="pubmed">21248165</ArticleId></ArticleIdList></Reference><Reference><Citation>Finlay B. B., Amato K. R., Azad M., Blaser M. J., Bosch T. C. G., Chu H., et al. (2021). The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome. Proc. Natl. Acad. Sci. U.S.A. 118: e2010217118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8017729</ArticleId><ArticleId IdType="pubmed">33472859</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedberg D. E., Chang L. (2022). Gastrointestinal symptoms in COVID-19: the long and the short of it. Curr. Opin. Gastroenterol. 38 555&#x2013;561. 10.1097/MOG.0000000000000876</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOG.0000000000000876</ArticleId><ArticleId IdType="pubmed">36165028</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaibani P., D&#x2019;amico F., Bartoletti M., Lombardo D., Rampelli S., Fornaro G., et al. (2021). The gut microbiota of critically Ill patients with COVID-19. Front. Cell. Infect. Microbiol. 11:670424. 10.3389/fcimb.2021.670424</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.670424</ArticleId><ArticleId IdType="pmc">PMC8276076</ArticleId><ArticleId IdType="pubmed">34268136</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasmi A., Noor S., Menzel A., Khanyk N., Semenova Y., Lysiuk R., et al. (2023). Potential drugs in COVID-19 management. Curr. Med. Chem. 10.2174/0929867331666230717154101</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867331666230717154101</ArticleId><ArticleId IdType="pubmed">37461346</ArticleId></ArticleIdList></Reference><Reference><Citation>Genedi M., Janmaat I. E., Haarman B., Sommer I. E. C. (2019). Dysregulation of the gut-brain axis in schizophrenia and bipolar disorder: probiotic supplementation as a supportive treatment in psychiatric disorders. Curr. Opin. Psychiatry 32 185&#x2013;195. 10.1097/YCO.0000000000000499</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/YCO.0000000000000499</ArticleId><ArticleId IdType="pubmed">30920970</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron L. B., Dweep H., Yin X., Wang H., Damra M., Goldman A. R., et al. (2021). Plasma markers of disrupted gut permeability in severe COVID-19 patients. Front. Immunol. 12:686240. 10.3389/fimmu.2021.686240</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686240</ArticleId><ArticleId IdType="pmc">PMC8219958</ArticleId><ArticleId IdType="pubmed">34177935</ArticleId></ArticleIdList></Reference><Reference><Citation>Gou W., Fu Y., Yue L., Chen G. D., Cai X., Shuai M., et al. (2021). Gut microbiota, inflammation, and molecular signatures of host response to infection. J. Genet. Genomics 48 792&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pubmed">34257044</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S., Chen Y., Wu Z., Chen Y., Gao H., Lv L., et al. (2020). Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza. Clin. Infect. Dis. 71 2669&#x2013;2678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314193</ArticleId><ArticleId IdType="pubmed">32497191</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W. J., Zhong N. S. (2020). Clinical characteristics of Covid-19 in China. reply. N. Engl. J. Med. 382 1861&#x2013;1862.</Citation><ArticleIdList><ArticleId IdType="pubmed">32220206</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Wang B., Gao H., Gao L., Hua R., Xu J. D. (2021). ACE2 in the gut: the center of the 2019-nCoV infected pathology. Front. Mol. Biosci. 8:708336. 10.3389/fmolb.2021.708336</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.708336</ArticleId><ArticleId IdType="pmc">PMC8493804</ArticleId><ArticleId IdType="pubmed">34631794</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez-Castrell&#xf3;n P., Gandara-Mart&#xed; T., Abreu Y. a. a. T., Nieto-Rufino C. D., L&#xf3;pez-Ordu&#xf1;a E., Jim&#xe9;nez-Escobar I., et al. (2022). Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial. Gut Microbes 14:2018899. 10.1080/19490976.2021.2018899</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.2018899</ArticleId><ArticleId IdType="pmc">PMC8757475</ArticleId><ArticleId IdType="pubmed">35014600</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajipour A., Afsharfar M., Jonoush M., Ahmadzadeh M., Gholamalizadeh M., Hassanpour Ardekanizadeh N., et al. (2022). The effects of dietary fiber on common complications in critically ill patients; with a special focus on viral infections; a systematic reveiw. Immun. Inflamm. Dis. 10:e613. 10.1002/iid3.613</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.613</ArticleId><ArticleId IdType="pmc">PMC9017620</ArticleId><ArticleId IdType="pubmed">35478440</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakim A., Hasan M. M., Hasan M., Lokman S. M., Azim K. F., Raihan T., et al. (2021). Major insights in dynamics of host response to SARS-CoV-2: impacts and challenges. Front. Microbiol. 12:637554. 10.3389/fmicb.2021.637554</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.637554</ArticleId><ArticleId IdType="pmc">PMC8424194</ArticleId><ArticleId IdType="pubmed">34512561</ArticleId></ArticleIdList></Reference><Reference><Citation>Han C., Duan C., Zhang S., Spiegel B., Shi H., Wang W., et al. (2020). Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes. Am. J. Gastroenterol. 115 916&#x2013;923. 10.14309/ajg.0000000000000664</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000664</ArticleId><ArticleId IdType="pmc">PMC7172493</ArticleId><ArticleId IdType="pubmed">32301761</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y., Duan X., Yang L., Nilsson-Payant B. E., Wang P., Duan F., et al. (2021). Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature 589 270&#x2013;275. 10.1038/s41586-020-2901-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2901-9</ArticleId><ArticleId IdType="pmc">PMC8034380</ArticleId><ArticleId IdType="pubmed">33116299</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto T., Perlot T., Rehman A., Trichereau J., Ishiguro H., Paolino M., et al. (2012). ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487 477&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095315</ArticleId><ArticleId IdType="pubmed">22837003</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinen A., Varghese S., Krayem A., Molodynski A. (2022). Understanding health anxiety in the COVID-19 pandemic. Int. J. Soc. Psychiatry 68 1756&#x2013;1763.</Citation><ArticleIdList><ArticleId IdType="pubmed">34823387</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., et al. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181 271&#x2013;280.e278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Howell M. C., Green R., Mcgill A. R., Dutta R., Mohapatra S., Mohapatra S. S. (2021). SARS-CoV-2-induced gut microbiome dysbiosis: implications for colorectal cancer. Cancers (Basel) 13:2676. 10.3390/cancers13112676</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13112676</ArticleId><ArticleId IdType="pmc">PMC8198029</ArticleId><ArticleId IdType="pubmed">34071688</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J., Zhang L., Lin W., Tang W., Chan F. K. L., Ng S. C. (2021). Review article: probiotics, prebiotics and dietary approaches during COVID-19 pandemic. Trends Food Sci. Technol. 108 187&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833886</ArticleId><ArticleId IdType="pubmed">33519087</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes S., Troise O., Donaldson H., Mughal N., Moore L. S. P. (2020). Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin. Microbiol. Infect. 26 1395&#x2013;1399. 10.1016/j.cmi.2020.06.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.06.025</ArticleId><ArticleId IdType="pmc">PMC7320692</ArticleId><ArticleId IdType="pubmed">32603803</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui W., Li T., Liu W., Zhou C., Gao F. (2019). Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis. PLoS One 14:e0210016. 10.1371/journal.pone.0210016</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0210016</ArticleId><ArticleId IdType="pmc">PMC6343888</ArticleId><ArticleId IdType="pubmed">30673716</ArticleId></ArticleIdList></Reference><Reference><Citation>Ianiro G., Bibb&#xf3; S., Masucci L., Quaranta G., Porcari S., Settanni C. R., et al. (2020a). Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study. Dig. Liver Dis. 52, 1390&#x2013;1395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7724982</ArticleId><ArticleId IdType="pubmed">33004295</ArticleId></ArticleIdList></Reference><Reference><Citation>Ianiro G., Mullish B. H., Kelly C. R., Kassam Z., Kuijper E. J., Ng S. C., et al. (2020b). Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic. Gut 69, 1555&#x2013;1563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7456726</ArticleId><ArticleId IdType="pubmed">32620549</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshee S., Vatti N., Chang C. (2022). Long-term effects of COVID-19. Mayo Clin. Proc. 97 579&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8752286</ArticleId><ArticleId IdType="pubmed">35246288</ArticleId></ArticleIdList></Reference><Reference><Citation>Juul F. E., Garborg K., Bretthauer M., Skudal H., &#xd8;ines M. N., Wiig H., et al. (2018). Fecal microbiota transplantation for primary Clostridium difficile infection. N. Engl. J. Med. 378, 2535&#x2013;2536.</Citation><ArticleIdList><ArticleId IdType="pubmed">29860912</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalantar-Zadeh K., Ward S. A., Kalantar-Zadeh K., El-Omar E. M. (2020). Considering the effects of microbiome and diet on SARS-CoV-2 infection: nanotechnology roles. ACS Nano 14 5179&#x2013;5182.</Citation><ArticleIdList><ArticleId IdType="pubmed">32356654</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawaratani H., Tsujimoto T., Douhara A., Takaya H., Moriya K., Namisaki T., et al. (2013). The effect of inflammatory cytokines in alcoholic liver disease. Mediators Inflamm. 2013:495156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3872233</ArticleId><ArticleId IdType="pubmed">24385684</ArticleId></ArticleIdList></Reference><Reference><Citation>Keita A. V., S&#xf6;derholm J. D., Ericson A. C. (2010). Stress-induced barrier disruption of rat follicle-associated epithelium involves corticotropin-releasing hormone, acetylcholine, substance P, and mast cells. Neurogastroenterol. Motil. 22 770&#x2013;778, e221&#x2013;e222. 10.1111/j.1365-2982.2010.01471.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2982.2010.01471.x</ArticleId><ArticleId IdType="pubmed">20149111</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M., Mathew B. J., Gupta P., Garg G., Khadanga S., Vyas A. K., et al. (2021). Gut dysbiosis and IL-21 response in patients with severe COVID-19. Microorganisms 9:1292. 10.3390/microorganisms9061292</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9061292</ArticleId><ArticleId IdType="pmc">PMC8231954</ArticleId><ArticleId IdType="pubmed">34199203</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;hbacher T., Ott S. J., Helwig U., Mimura T., Rizzello F., Kleessen B., et al. (2006). Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 55 833&#x2013;841. 10.1136/gut.2005.078303</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2005.078303</ArticleId><ArticleId IdType="pmc">PMC1856240</ArticleId><ArticleId IdType="pubmed">16401690</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., De Souza R., Nadkar M., Guleria R., Trikha A., Joshi S. R., et al. (2021). A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19. Expert Opin. Biol. Ther. 21 675&#x2013;686. 10.1080/14712598.2021.1905794</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14712598.2021.1905794</ArticleId><ArticleId IdType="pmc">PMC8040494</ArticleId><ArticleId IdType="pubmed">33835886</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers M. M., Beumer J., Van Der Vaart J., Knoops K., Puschhof J., Breugem T. I., et al. (2020). SARS-CoV-2 productively infects human gut enterocytes. Science 369 50&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei W. T., Shih P. C., Liu S. J., Lin C. Y., Yeh T. L. (2017). Effect of probiotics and prebiotics on immune response to influenza vaccination in adults: a systematic review and meta-analysis of randomized controlled trials. Nutrients 9:1175. 10.3390/nu9111175</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9111175</ArticleId><ArticleId IdType="pmc">PMC5707647</ArticleId><ArticleId IdType="pubmed">29077061</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine R. L. (2022). Addressing the long-term effects of COVID-19. JAMA 328 823&#x2013;824.</Citation><ArticleIdList><ArticleId IdType="pubmed">35921084</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Wu Y., Wang J., Yan H., Lu J., Wang Y., et al. (2022). Potential treatment of COVID-19 with traditional Chinese medicine: what herbs can help win the battle with SARS-CoV-2? Engineering (Beijing) 19 139&#x2013;152. 10.1016/j.eng.2021.08.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eng.2021.08.020</ArticleId><ArticleId IdType="pmc">PMC8552808</ArticleId><ArticleId IdType="pubmed">34729244</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Cheng F., Xu Q., Su Y., Cai X., Zeng F., et al. (2021). The role of probiotics in coronavirus disease-19 infection in Wuhan: a retrospective study of 311 severe patients. Int. Immunopharmacol. 95:107531. 10.1016/j.intimp.2021.107531</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107531</ArticleId><ArticleId IdType="pmc">PMC7934664</ArticleId><ArticleId IdType="pubmed">33714884</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Yang S., Zhou Y., Disoma C., Dong Z., Du A., et al. (2021). Microbiome profiling using shotgun metagenomic sequencing identified unique microorganisms in COVID-19 patients with altered gut microbiota. Front. Microbiol. 12:712081. 10.3389/fmicb.2021.712081</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.712081</ArticleId><ArticleId IdType="pmc">PMC8542975</ArticleId><ArticleId IdType="pubmed">34707577</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Zeng Z., Li Y., Huang W., Zhou M., Zhang X., et al. (2015). Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation. Shock 43 395&#x2013;404. 10.1097/SHK.0000000000000302</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000000302</ArticleId><ArticleId IdType="pubmed">25768373</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W., Feng Z., Rao S., Xiao C., Xue X., Lin Z., et al. (2020). Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus. Gut 69 1141&#x2013;1143.</Citation><ArticleIdList><ArticleId IdType="pubmed">32102928</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., Jiang X., Zhang Z., Huang S., Zhang Z., Fang Z., et al. (2020). Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut 69 997&#x2013;1001.</Citation><ArticleIdList><ArticleId IdType="pubmed">32241899</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Ye S., Zhu X., He X., Wang S., Li Y., et al. (2021). Gastrointestinal disturbance and effect of fecal microbiota transplantation in discharged COVID-19 patients. J. Med. Case Rep. 15:60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7868905</ArticleId><ArticleId IdType="pubmed">33557941</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J. W. Y., Su Q., Yeoh Y. K., Lui G. C., Ng S. S. S., et al. (2022). Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut 71 544&#x2013;552. 10.1136/gutjnl-2021-325989</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Yang Y., Zhang C., Huang F., Wang F., Yuan J., et al. (2020). Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci. China Life Sci. 63 364&#x2013;374. 10.1007/s11427-020-1643-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-020-1643-8</ArticleId><ArticleId IdType="pmc">PMC7088566</ArticleId><ArticleId IdType="pubmed">32048163</ArticleId></ArticleIdList></Reference><Reference><Citation>Llorens S., Nava E., Mu&#xf1;oz-L&#xf3;pez M., S&#xe1;nchez-Larsen &#xc1;., Segura T. (2021). Neurological symptoms of COVID-19: the zonulin hypothesis. Front. Immunol. 12:665300. 10.3389/fimmu.2021.665300</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.665300</ArticleId><ArticleId IdType="pmc">PMC8107207</ArticleId><ArticleId IdType="pubmed">33981312</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., et al. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395 565&#x2013;574. 10.1016/S0140-6736(20)30251-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y., Xue Y., Mao L., Yuan X., Lin Q., Tang G., et al. (2020). Prealbumin as a predictor of prognosis in patients with coronavirus disease 2019. Front. Med. (Lausanne) 7:374. 10.3389/fmed.2020.00374</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00374</ArticleId><ArticleId IdType="pmc">PMC7333015</ArticleId><ArticleId IdType="pubmed">32671085</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynn D. J., Benson S. C., Lynn M. A., Pulendran B. (2022). Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms. Nat. Rev. Immunol. 22 33&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8127454</ArticleId><ArticleId IdType="pubmed">34002068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C., Cong Y., Zhang H. (2020). COVID-19 and the digestive system. Am. J. Gastroenterol. 115 1003&#x2013;1006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273952</ArticleId><ArticleId IdType="pubmed">32618648</ArticleId></ArticleIdList></Reference><Reference><Citation>Mack D. R., Ahrne S., Hyde L., Wei S., Hollingsworth M. A. (2003). Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52 827&#x2013;833. 10.1136/gut.52.6.827</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.52.6.827</ArticleId><ArticleId IdType="pmc">PMC1773687</ArticleId><ArticleId IdType="pubmed">12740338</ArticleId></ArticleIdList></Reference><Reference><Citation>Majidi N., Bahadori E., Shekari S., Gholamalizadeh M., Tajadod S., Ajami M., et al. (2022). Effects of supplementation with low-dose group B vitamins on clinical and biochemical parameters in critically ill patients with COVID-19: a randomized clinical trial. Expert Rev. Anti Infect. Ther. 1&#x2013;7. 10.1080/14787210.2022.2125867</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2022.2125867</ArticleId><ArticleId IdType="pubmed">36108676</ArticleId></ArticleIdList></Reference><Reference><Citation>Majidi N., Rabbani F., Gholami S., Gholamalizadeh M., Bourbour F., Rastgoo S., et al. (2021). The effect of vitamin C on pathological parameters and survival duration of critically Ill coronavirus disease 2019 patients: a randomized clinical trial. Front. Immunol. 12:717816. 10.3389/fimmu.2021.717816</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.717816</ArticleId><ArticleId IdType="pmc">PMC8714637</ArticleId><ArticleId IdType="pubmed">34975830</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder J., Minko T. (2021). Recent developments on therapeutic and diagnostic approaches for COVID-19. AAPS J. 23:14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7784226</ArticleId><ArticleId IdType="pubmed">33400058</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak J. W. Y., Chan F. K. L., Ng S. C. (2020). Probiotics and COVID-19: one size does not fit all. Lancet Gastroenterol. Hepatol. 5 644&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7182525</ArticleId><ArticleId IdType="pubmed">32339473</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansell V., Hall Dykgraaf S., Kidd M., Goodyear-Smith F. (2022). Long COVID and older people. Lancet Healthy Longev. 3 e849&#x2013;e854.</Citation><ArticleIdList><ArticleId IdType="pubmed">36480981</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzoor R., Ahmed W., Afify N., Memon M., Yasin M., Memon H., et al. (2022). Trust your gut: the association of gut microbiota and liver disease. Microorganisms 10:1045. 10.3390/microorganisms10051045</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10051045</ArticleId><ArticleId IdType="pmc">PMC9146349</ArticleId><ArticleId IdType="pubmed">35630487</ArticleId></ArticleIdList></Reference><Reference><Citation>Marotz C., Belda-Ferre P., Ali F., Das P., Huang S., Cantrell K., et al. (2021). SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environment. Microbiome 9:132. 10.1186/s40168-021-01083-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-021-01083-0</ArticleId><ArticleId IdType="pmc">PMC8186369</ArticleId><ArticleId IdType="pubmed">34103074</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsico C., Capretti M. G., Aceti A., Vocale C., Carfagnini F., Serra C., et al. (2022). Severe neonatal COVID-19: challenges in management and therapeutic approach. J. Med. Virol. 94 1701&#x2013;1706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9011600</ArticleId><ArticleId IdType="pubmed">34812530</ArticleId></ArticleIdList></Reference><Reference><Citation>Merino J., Joshi A. D., Nguyen L. H., Leeming E. R., Mazidi M., Drew D. A., et al. (2021). Diet quality and risk and severity of COVID-19: a prospective cohort study. Gut 70 2096&#x2013;2104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500931</ArticleId><ArticleId IdType="pubmed">34489306</ArticleId></ArticleIdList></Reference><Reference><Citation>Mimura T., Rizzello F., Helwig U., Poggioli G., Schreiber S., Talbot I. C., et al. (2004). Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53 108&#x2013;114. 10.1136/gut.53.1.108</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.53.1.108</ArticleId><ArticleId IdType="pmc">PMC1773918</ArticleId><ArticleId IdType="pubmed">14684584</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrea L., Neme&#x15f; S. A., Szabo K., Teleky B. E., Vodnar D. C. (2022). Guts imbalance imbalances the brain: a review of gut microbiota association with neurological and psychiatric disorders. Front. Med. (Lausanne) 9:813204. 10.3389/fmed.2022.813204</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.813204</ArticleId><ArticleId IdType="pmc">PMC9009523</ArticleId><ArticleId IdType="pubmed">35433746</ArticleId></ArticleIdList></Reference><Reference><Citation>Moludi J., Qaisar S. A., Alizadeh M., Jafari Vayghan H., Naemi M., Rahimi A., et al. (2022). The relationship between Dietary Inflammatory Index and disease severity and inflammatory status: a case-control study of COVID-19 patients. Br. J. Nutr. 127 773&#x2013;781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8446593</ArticleId><ArticleId IdType="pubmed">34420546</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair G. B., Niederman M. S. (2021). Updates on community acquired pneumonia management in the ICU. Pharmacol. Ther. 217:107663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7428725</ArticleId><ArticleId IdType="pubmed">32805298</ArticleId></ArticleIdList></Reference><Reference><Citation>Najmi N., Megantara I., Andriani L., Goenawan H., Lesmana R. (2022). Importance of gut microbiome regulation for the prevention and recovery process after SARS-CoV-2 respiratory viral infection (Review). Biomed. Rep. 16:25. 10.3892/br.2022.1508</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/br.2022.1508</ArticleId><ArticleId IdType="pmc">PMC8889546</ArticleId><ArticleId IdType="pubmed">35251612</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A., Zlitni S., Brooks E. F., Vance S. E., Dahlen A., Hedlin H., et al. (2022). Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med 3 371&#x2013;387.e379. 10.1016/j.medj.2022.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurath M. F. (2020). COVID-19 and immunomodulation in IBD. Gut 69 1335&#x2013;1342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211083</ArticleId><ArticleId IdType="pubmed">32303609</ArticleId></ArticleIdList></Reference><Reference><Citation>Newsome R. C., Gauthier J., Hernandez M. C., Abraham G. E., Robinson T. O., Williams H. B., et al. (2021). The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort. Gut Microbes 13 1&#x2013;15. 10.1080/19490976.2021.1926840</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.1926840</ArticleId><ArticleId IdType="pmc">PMC8205023</ArticleId><ArticleId IdType="pubmed">34100340</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng S. C., Peng Y., Zhang L., Mok C. K., Zhao S., Li A., et al. (2022). Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events. Gut 71 1106&#x2013;1116. 10.1136/gutjnl-2021-326563</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-326563</ArticleId><ArticleId IdType="pmc">PMC8844967</ArticleId><ArticleId IdType="pubmed">35140064</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng T. M., Ong S. W. X., Loo A. Y. X., Tan S. H., Tay H. L., Yap M. Y., et al. (2022). Antibiotic therapy in the treatment of COVID-19 pneumonia: who and when? Antibiotics (Basel) 11:184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8868256</ArticleId><ArticleId IdType="pubmed">35203787</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholl B. I., Halder S. L., Macfarlane G. J., Thompson D. G., O&#x2019;brien S., Musleh M., et al. (2008). Psychosocial risk markers for new onset irritable bowel syndrome&#x2013;results of a large prospective population-based study. Pain 137 147&#x2013;155. 10.1016/j.pain.2007.08.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2007.08.029</ArticleId><ArticleId IdType="pmc">PMC2441776</ArticleId><ArticleId IdType="pubmed">17928145</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojetti V., Saviano A., Covino M., Acampora N., Troiani E., Franceschi F. (2020). COVID-19 and intestinal inflammation: role of fecal calprotectin. Dig. Liver Dis. 52 1231&#x2013;1233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7508507</ArticleId><ArticleId IdType="pubmed">33060042</ArticleId></ArticleIdList></Reference><Reference><Citation>Olaimat A. N., Aolymat I., Al-Holy M., Ayyash M., Abu Ghoush M., Al-Nabulsi A. A., et al. (2020). The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19. NPJ Sci. Food 4:17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536434</ArticleId><ArticleId IdType="pubmed">33083549</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong J., Young B. E., Ong S. (2020). COVID-19 in gastroenterology: a clinical perspective. Gut 69 1144&#x2013;1145.</Citation><ArticleIdList><ArticleId IdType="pubmed">32198152</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterlund P., Ruotsalainen T., Korpela R., Saxelin M., Ollus A., Valta P., et al. (2007). Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br. J. Cancer 97 1028&#x2013;1034. 10.1038/sj.bjc.6603990</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjc.6603990</ArticleId><ArticleId IdType="pmc">PMC2360429</ArticleId><ArticleId IdType="pubmed">17895895</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomino-Kobayashi L. A., Yma&#xf1;a B., Ruiz J., Mayanga-Herrera A., Ugarte-Gil M. F., Pons M. J. (2022). Zonulin, a marker of gut permeability, is associated with mortality in a cohort of hospitalised peruvian COVID-19 patients. Front. Cell. Infect. Microbiol. 12:1000291. 10.3389/fcimb.2022.1000291</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.1000291</ArticleId><ArticleId IdType="pmc">PMC9485714</ArticleId><ArticleId IdType="pubmed">36147602</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L., Mu M., Yang P., Sun Y., Wang R., Yan J., et al. (2020). Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am. J. Gastroenterol. 115 766&#x2013;773. 10.14309/ajg.0000000000000620</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000620</ArticleId><ArticleId IdType="pmc">PMC7172492</ArticleId><ArticleId IdType="pubmed">32287140</ArticleId></ArticleIdList></Reference><Reference><Citation>Panda P. K., Bandyopadhyay A., Singh B. C., Moirangthem B., Chikara G., Saha S., et al. (2020). Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): a structured summary of a study protocol for a randomized controlled trial. Trials 21:866. 10.1186/s13063-020-04774-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-020-04774-5</ArticleId><ArticleId IdType="pmc">PMC7573526</ArticleId><ArticleId IdType="pubmed">33081849</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker A. M., Jackson N., Awasthi S., Kim H., Alwan T., Wyllie A. L., et al. (2022). Association of upper respiratory Streptococcus pneumoniae colonization with SARS-CoV-2 infection among adults. Clin. Infect. Dis. ciac907.</Citation><ArticleIdList><ArticleId IdType="pubmed">36401872</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad R., Patton M. J., Floyd J. L., Fortmann S., Dupont M., Harbour A., et al. (2022). Plasma microbiome in COVID-19 subjects: an indicator of gut barrier defects and dysbiosis. Int. J. Mol. Sci. 23:9141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9409329</ArticleId><ArticleId IdType="pubmed">36012406</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulendran B. (2019). Immunology taught by vaccines. Science 366 1074&#x2013;1075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8196409</ArticleId><ArticleId IdType="pubmed">31780544</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian Q., Fan L., Liu W., Li J., Yue J., Wang M., et al. (2021). Direct evidence of active SARS-CoV-2 replication in the intestine. Clin. Infect. Dis. 73 361&#x2013;366. 10.1093/cid/ciaa925</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa925</ArticleId><ArticleId IdType="pmc">PMC7454471</ArticleId><ArticleId IdType="pubmed">32638022</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao L., Huang W., Zhang X., Guo H., Wang D., Feng Q., et al. (2021). Evaluation of the immunomodulatory effects of anti-COVID-19 TCM formulae by multiple virus-related pathways. Signal Transduct. Target. Ther. 6:50. 10.1038/s41392-021-00475-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00475-w</ArticleId><ArticleId IdType="pmc">PMC7860167</ArticleId><ArticleId IdType="pubmed">33542177</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahaman M. M., Sarkar M. M. H., Rahman M. S., Islam M. R., Islam I., Saha O., et al. (2022). Genomic characterization of the dominating Beta, V2 variant carrying vaccinated (Oxford-AstraZeneca) and nonvaccinated COVID-19 patient samples in Bangladesh: a metagenomics and whole-genome approach. J. Med. Virol. 94 1670&#x2013;1688. 10.1002/jmv.27537</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27537</ArticleId><ArticleId IdType="pubmed">34939673</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajput S., Paliwal D., Naithani M., Kothari A., Meena K., Rana S. (2021). COVID-19 and gut microbiota: a potential connection. Indian J. Clin. Biochem. 36 266&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7818076</ArticleId><ArticleId IdType="pubmed">33495676</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiff C., Kelly D. (2010). Inflammatory bowel disease, gut bacteria and probiotic therapy. Int. J. Med. Microbiol. 300 25&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">19800289</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z., Wang H., Cui G., Lu H., Wang L., Luo H., et al. (2021). Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut 70 1253&#x2013;1265. 10.1136/gutjnl-2020-323826</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323826</ArticleId><ArticleId IdType="pmc">PMC8042598</ArticleId><ArticleId IdType="pubmed">33789966</ArticleId></ArticleIdList></Reference><Reference><Citation>Romani L., Del Chierico F., Macari G., Pane S., Ristori M. V., Guarrasi V., et al. (2022). The relationship between pediatric gut microbiota and SARS-CoV-2 infection. Front. Cell. Infect. Microbiol. 12:908492. 10.3389/fcimb.2022.908492</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.908492</ArticleId><ArticleId IdType="pmc">PMC9304937</ArticleId><ArticleId IdType="pubmed">35873161</ArticleId></ArticleIdList></Reference><Reference><Citation>Runfeng L., Yunlong H., Jicheng H., Weiqi P., Qinhai M., Yongxia S., et al. (2020). Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacol. Res. 156:104761.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102548</ArticleId><ArticleId IdType="pubmed">32205232</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartor R. B. (2006). Mechanisms of disease: pathogenesis of Crohn&#x2019;s disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3 390&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pubmed">16819502</ArticleId></ArticleIdList></Reference><Reference><Citation>Schult D., Reitmeier S., Koyumdzhieva P., Lahmer T., Middelhoff M., Erber J., et al. (2022). Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19. Gut Microbes 14 2031840. 10.1080/19490976.2022.2031840</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2022.2031840</ArticleId><ArticleId IdType="pmc">PMC8855857</ArticleId><ArticleId IdType="pubmed">35174781</ArticleId></ArticleIdList></Reference><Reference><Citation>Seibert B., C&#xe1;ceres C. J., Cardenas-Garcia S., Carnaccini S., Geiger G., Rajao D. S., et al. (2021). Mild and severe SARS-CoV-2 infection induces respiratory and intestinal microbiome changes in the K18-hACE2 transgenic mouse model. Microbiol. Spectr. 9:e0053621. 10.1128/Spectrum.00536-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/Spectrum.00536-21</ArticleId><ArticleId IdType="pmc">PMC8455067</ArticleId><ArticleId IdType="pubmed">34378965</ArticleId></ArticleIdList></Reference><Reference><Citation>Sencio V., Machelart A., Robil C., Benech N., Hoffmann E., Galbert C., et al. (2022). Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters. Gut Microbes 14:2018900. 10.1080/19490976.2021.2018900</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.2018900</ArticleId><ArticleId IdType="pmc">PMC8726722</ArticleId><ArticleId IdType="pubmed">34965194</ArticleId></ArticleIdList></Reference><Reference><Citation>Shchikota A. M., Pogonchenkova I. V., Turova E. A., Starodubova A. V., Nosova N. V. (2021). [COVID-19-associated diarrhea]. Vopr. Pitan. 90 18&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">35032121</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf6;derholm J. D., Yang P. C., Ceponis P., Vohra A., Riddell R., Sherman P. M., et al. (2002). Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology 123 1099&#x2013;1108. 10.1053/gast.2002.36019</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/gast.2002.36019</ArticleId><ArticleId IdType="pubmed">12360472</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J. B., Murthy S., Marshall J. C., Relan P., Diaz J. V. (2022). A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 22 e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Suez J., Zmora N., Segal E., Elinav E. (2019). The pros, cons, and many unknowns of probiotics. Nat. Med. 25 716&#x2013;729. 10.1038/s41591-019-0439-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0439-x</ArticleId><ArticleId IdType="pubmed">31061539</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Qian J., Xu X., Tang Y., Xu W., Yang W., et al. (2018). Dendritic cell-targeted recombinant Lactobacilli induce DC activation and elicit specific immune responses against G57 genotype of avian H9N2 influenza virus infection. Vet. Microbiol. 223 9&#x2013;20. 10.1016/j.vetmic.2018.07.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2018.07.009</ArticleId><ArticleId IdType="pubmed">30173758</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z., Song Z. G., Liu C., Tan S., Lin S., Zhu J., et al. (2022). Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients. BMC Med. 20:24. 10.1186/s12916-021-02212-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02212-0</ArticleId><ArticleId IdType="pmc">PMC8769945</ArticleId><ArticleId IdType="pubmed">35045853</ArticleId></ArticleIdList></Reference><Reference><Citation>Szeto C. C., Kwan B. C., Chow K. M., Lai K. B., Chung K. Y., Leung C. B., et al. (2008). Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clin. J. Am. Soc. Nephrol. 3 431&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2390956</ArticleId><ArticleId IdType="pubmed">18256376</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H., Bohannon L., Lew M., Jensen D., Jung S. H., Zhao A., et al. (2021). Randomised, double-blind, placebo-controlled trial of Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC): a clinical trial protocol. BMJ Open 11:e047069. 10.1136/bmjopen-2020-047069</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-047069</ArticleId><ArticleId IdType="pmc">PMC8102858</ArticleId><ArticleId IdType="pubmed">33952552</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L., Gu S., Gong Y., Li B., Lu H., Li Q., et al. (2020). Clinical significance of the correlation between changes in the major intestinal bacteria species and COVID-19 severity. Engineering (Beijing) 6 1178&#x2013;1184. 10.1016/j.eng.2020.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eng.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7832131</ArticleId><ArticleId IdType="pubmed">33520333</ArticleId></ArticleIdList></Reference><Reference><Citation>Tankou S. K., Regev K., Healy B. C., Cox L. M., Tjon E., Kivisakk P., et al. (2018). Investigation of probiotics in multiple sclerosis. Mult. Scler. 24 58&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">29307299</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao W., Wang X., Zhang G., Guo M., Ma H., Zhao D., et al. (2021). Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection. Protein Cell 12 230&#x2013;235. 10.1007/s13238-020-00778-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-020-00778-8</ArticleId><ArticleId IdType="pmc">PMC7518948</ArticleId><ArticleId IdType="pubmed">32978728</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor S. (2022). The psychology of pandemics. Annu. Rev. Clin. Psychol. 18 581&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pubmed">34780260</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y., Rong L., Nian W., He Y. (2020). Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment. Pharmacol. Ther. 51 843&#x2013;851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7161803</ArticleId><ArticleId IdType="pubmed">32222988</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y., Sun K. Y., Meng T. Q., Ye Z., Guo S. M., Li Z. M., et al. (2021). Gut microbiota may not be fully restored in recovered COVID-19 patients after 3-month recovery. Front. Nutr. 8:638825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155354</ArticleId><ArticleId IdType="pubmed">34055851</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomkinson S., Triscott C., Schenk E., Foey A. (2023). The potential of probiotics as ingestible adjuvants and immune modulators for antiviral immunity and management of SARS-CoV-2 infection and COVID-19. Pathogens 12:928. 10.3390/pathogens12070928</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens12070928</ArticleId><ArticleId IdType="pmc">PMC10384479</ArticleId><ArticleId IdType="pubmed">37513775</ArticleId></ArticleIdList></Reference><Reference><Citation>Triana S., Metz-Zumaran C., Ramirez C., Kee C., Doldan P., Shahraz M., et al. (2021). Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut. Mol. Syst. Biol. 17:e10232. 10.15252/msb.202110232</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.202110232</ArticleId><ArticleId IdType="pmc">PMC8077299</ArticleId><ArticleId IdType="pubmed">33904651</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi A., Debelius J., Brenner D. A., Karin M., Loomba R., Schnabl B., et al. (2018). The gut-liver axis and the intersection with the microbiome. Nat. Rev. Gastroenterol. Hepatol. 15 397&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6319369</ArticleId><ArticleId IdType="pubmed">29748586</ArticleId></ArticleIdList></Reference><Reference><Citation>Trompette A., Gollwitzer E. S., Pattaroni C., Lopez-Mejia I. C., Riva E., Pernot J., et al. (2018). Dietary fiber confers protection against flu by shaping Ly6c(-) patrolling monocyte hematopoiesis and CD8(+) T cell metabolism. Immunity 48 992&#x2013;1005.e1008. 10.1016/j.immuni.2018.04.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.04.022</ArticleId><ArticleId IdType="pubmed">29768180</ArticleId></ArticleIdList></Reference><Reference><Citation>Trottein F., Sokol H. (2020). Potential causes and consequences of gastrointestinal disorders during a SARS-CoV-2 infection. Cell Rep. 32:107915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332457</ArticleId><ArticleId IdType="pubmed">32649864</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhyay V., Suryawanshi R. K., Tasoff P., Mccavitt-Malvido M., Kumar R. G., Murray V. W., et al. (2023). Mild SARS-CoV-2 infection results in long-lasting microbiota instability. mBio 14:e0088923.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10470529</ArticleId><ArticleId IdType="pubmed">37294090</ArticleId></ArticleIdList></Reference><Reference><Citation>Venzon M., Cadwell K. (2022). COVID-19 and the forgotten organ: prolonged changes to the metabolic output of the gut microbiome. Gastroenterology 162 394&#x2013;396. 10.1053/j.gastro.2021.11.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.11.017</ArticleId><ArticleId IdType="pmc">PMC8596650</ArticleId><ArticleId IdType="pubmed">34800482</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdecchia P., Cavallini C., Spanevello A., Angeli F. (2020). The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur. J. Intern. Med. 76 14&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167588</ArticleId><ArticleId IdType="pubmed">32336612</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestad B., Ueland T., Lerum T. V., Dahl T. B., Holm K., Barratt-Due A., et al. (2022). Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations. J. Intern. Med. 291 801&#x2013;812. 10.1111/joim.13458</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13458</ArticleId><ArticleId IdType="pmc">PMC9115297</ArticleId><ArticleId IdType="pubmed">35212063</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicario M., Guilarte M., Alonso C., Yang P., Mart&#xed;nez C., Ramos L., et al. (2010). Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress. Brain Behav. Immun. 24 1166&#x2013;1175. 10.1016/j.bbi.2010.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2010.06.002</ArticleId><ArticleId IdType="pubmed">20600818</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignesh R., Swathirajan C. R., Tun Z. H., Rameshkumar M. R., Solomon S. S., Balakrishnan P. (2020). Could perturbation of gut microbiota possibly exacerbate the severity of COVID-19 via cytokine storm? Front. Immunol. 11:607734. 10.3389/fimmu.2020.607734</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.607734</ArticleId><ArticleId IdType="pmc">PMC7868418</ArticleId><ArticleId IdType="pubmed">33569053</ArticleId></ArticleIdList></Reference><Reference><Citation>Villapol S. (2020). Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome. Transl. Res. 226 57&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438210</ArticleId><ArticleId IdType="pubmed">32827705</ArticleId></ArticleIdList></Reference><Reference><Citation>Vodnar D. C., Mitrea L., Teleky B. E., Szabo K., C&#xe3;linoiu L. F., Neme&#x15f; S. A., et al. (2020). Coronavirus disease (COVID-19) caused by (SARS-CoV-2) infections: a real challenge for human gut microbiota. Front. Cell. Infect. Microbiol. 10:575559. 10.3389/fcimb.2020.575559</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.575559</ArticleId><ArticleId IdType="pmc">PMC7756003</ArticleId><ArticleId IdType="pubmed">33363049</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada M., Nagata S., Saito M., Shimizu T., Yamashiro Y., Matsuki T., et al. (2010). Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Support. Care Cancer 18 751&#x2013;759. 10.1007/s00520-009-0711-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-009-0711-6</ArticleId><ArticleId IdType="pubmed">19685085</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan Y., Li J., Shen L., Zou Y., Hou L., Zhu L., et al. (2020). Enteric involvement in hospitalised patients with COVID-19 outside Wuhan. Lancet Gastroenterol. Hepatol. 5 534&#x2013;535. 10.1016/S2468-1253(20)30118-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30118-7</ArticleId><ArticleId IdType="pmc">PMC7159861</ArticleId><ArticleId IdType="pubmed">32304638</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M. Y., Zhao R., Gao L. J., Gao X. F., Wang D. P., Cao J. M. (2020). SARS-CoV-2: structure, biology, and structure-based therapeutics development. Front. Cell. Infect. Microbiol. 10:587269. 10.3389/fcimb.2020.587269</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.587269</ArticleId><ArticleId IdType="pmc">PMC7723891</ArticleId><ArticleId IdType="pubmed">33324574</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Fu T., Hao J., Li L., Tian M., Jin N., et al. (2020). A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2. Int. J. Biol. Macromol. 160 736&#x2013;740. 10.1016/j.ijbiomac.2020.05.239</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2020.05.239</ArticleId><ArticleId IdType="pmc">PMC7260514</ArticleId><ArticleId IdType="pubmed">32485251</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Liu B., Huang J., He H., Zhou L., He Y., et al. (2023). Succinate and mitochondrial DNA trigger atopic march from atopic dermatitis to intestinal inflammation. J. Allergy Clin. Immunol. 151 1050&#x2013;1066.e1057. 10.1016/j.jaci.2022.11.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2022.11.026</ArticleId><ArticleId IdType="pubmed">36587852</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Wu G., Zhao L., Wang W. (2022). Nutritional modulation of gut microbiota alleviates severe gastrointestinal symptoms in a patient with post-acute COVID-19 syndrome. mBio 13:e0380121. 10.1128/mbio.03801-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.03801-21</ArticleId><ArticleId IdType="pmc">PMC9040862</ArticleId><ArticleId IdType="pubmed">35254129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Yang L., Song X. Q. (2022). Oral GS-441524 derivatives: next-generation inhibitors of SARS-CoV-2 RNA-dependent RNA polymerase. Front. Immunol. 13:1015355. 10.3389/fimmu.2022.1015355</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1015355</ArticleId><ArticleId IdType="pmc">PMC9763260</ArticleId><ArticleId IdType="pubmed">36561747</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei D., Heus P., Van De Wetering F. T., Van Tienhoven G., Verleye L., Scholten R. J. (2018). Probiotics for the prevention or treatment of chemotherapy- or radiotherapy-related diarrhoea in people with cancer. Cochrane Database Syst. Rev. 8:Cd008831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6513393</ArticleId><ArticleId IdType="pubmed">30168576</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng J., Li Y., Li J., Shen L., Zhu L., Liang Y., et al. (2021). Gastrointestinal sequelae 90 days after discharge for COVID-19. Lancet Gastroenterol. Hepatol. 6 344&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7943402</ArticleId><ArticleId IdType="pubmed">33711290</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff L., Martiny D., Deyi V. Y. M., Maillart E., Clevenbergh P., Dauby N. (2021). COVID-19-associated Fusobacterium nucleatum Bacteremia, Belgium. Emerg. Infect. Dis. 27 975&#x2013;977. 10.3201/eid2703.202284</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2703.202284</ArticleId><ArticleId IdType="pmc">PMC7920680</ArticleId><ArticleId IdType="pubmed">33292922</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Cheng X., Jiang G., Tang H., Ming S., Tang L., et al. (2021). Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. NPJ Biofilms Microbiomes 7:61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298611</ArticleId><ArticleId IdType="pubmed">34294722</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Guo C., Tang L., Hong Z., Zhou J., Dong X., et al. (2020). Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol. Hepatol. 5 434&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158584</ArticleId><ArticleId IdType="pubmed">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F., Tang M., Zheng X., Liu Y., Li X., Shan H. (2020). Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 158 1831&#x2013;1833.e1833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7130181</ArticleId><ArticleId IdType="pubmed">32142773</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Chen H. B., Li S. L. (2017). Understanding the molecular mechanisms of the interplay between herbal medicines and gut microbiota. Med. Res. Rev. 37 1140&#x2013;1185.</Citation><ArticleIdList><ArticleId IdType="pubmed">28052344</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., Zhang T., Cui B., He Z., Xiang J., Long C., et al. (2016). Clinical efficacy maintains patients&#x2019; positive attitudes toward fecal microbiota transplantation. Medicine 95:e4055.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5265816</ArticleId><ArticleId IdType="pubmed">27472679</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R., Lu R., Zhang T., Wu Q., Cai W., Han X., et al. (2021). Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults. Commun. Biol. 4:240. 10.1038/s42003-021-01796-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-01796-w</ArticleId><ArticleId IdType="pmc">PMC7893062</ArticleId><ArticleId IdType="pubmed">33603076</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Zhang W., Guo M., Xiao C., Fu Z., Yu S., et al. (2022). Integrated analysis of gut microbiome and host immune responses in COVID-19. Front. Med. 16:263&#x2013;275. 10.1007/s11684-022-0921-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-022-0921-6</ArticleId><ArticleId IdType="pmc">PMC8902486</ArticleId><ArticleId IdType="pubmed">35258762</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Li X., Zhu B., Liang H., Fang C., Gong Y., et al. (2020). Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat. Med. 26 502&#x2013;505. 10.1038/s41591-020-0817-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0817-4</ArticleId><ArticleId IdType="pmc">PMC7095102</ArticleId><ArticleId IdType="pubmed">32284613</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T., Chakraborty S., Saha P., Mell B., Cheng X., Yeo J. Y., et al. (2020). Gnotobiotic rats reveal that gut microbiota regulates colonic mRNA of Ace2, the receptor for SARS-CoV-2 Infectivity. Hypertension 76, e1&#x2013;e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7379164</ArticleId><ArticleId IdType="pubmed">32426999</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y. K., Zuo T., Lui G. C., Zhang F., Liu Q., Li A. Y., et al. (2021). Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 70 698&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Young B. E., Ong S. W. X., Kalimuddin S., Low J. G., Tan S. Y., Loh J., et al. (2020). Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 323 1488&#x2013;1494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7054855</ArticleId><ArticleId IdType="pubmed">32125362</ArticleId></ArticleIdList></Reference><Reference><Citation>Zabetakis I., Lordan R., Norton C., Tsoupras A. (2020). COVID-19: the inflammation link and the role of nutrition in potential mitigation. Nutrients 12:1466. 10.3390/nu12051466</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12051466</ArticleId><ArticleId IdType="pmc">PMC7284818</ArticleId><ArticleId IdType="pubmed">32438620</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng F. M., Li Y. W., Deng Z. H., He J. Z., Li W., Wang L., et al. (2022). SARS-CoV-2 spike spurs intestinal inflammation via VEGF production in enterocytes. EMBO Mol. Med. 14:e14844. 10.15252/emmm.202114844</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202114844</ArticleId><ArticleId IdType="pmc">PMC9081906</ArticleId><ArticleId IdType="pubmed">35362189</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Wan Y., Zuo T., Yeoh Y. K., Liu Q., Zhang L., et al. (2022). Prolonged impairment of short-chain fatty acid and L-isoleucine biosynthesis in gut microbiome in patients with COVID-19. Gastroenterology 162 548&#x2013;561.e544. 10.1053/j.gastro.2021.10.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.10.013</ArticleId><ArticleId IdType="pmc">PMC8529231</ArticleId><ArticleId IdType="pubmed">34687739</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., He Z., Yu G., Peng D., Feng Y., Ling J., et al. (2021). The modified NUTRIC score can be used for nutritional risk assessment as well as prognosis prediction in critically ill COVID-19 patients. Clin. Nutr. 40 534&#x2013;541. 10.1016/j.clnu.2020.05.051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2020.05.051</ArticleId><ArticleId IdType="pmc">PMC7273137</ArticleId><ArticleId IdType="pubmed">32527576</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Zhang G., Guo M., Tao W., Liu X., Wei H., et al. (2021). The potential role of an aberrant mucosal immune response to SARS-CoV-2 in the pathogenesis of IgA nephropathy. Pathogens 10:881. 10.3390/pathogens10070881</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10070881</ArticleId><ArticleId IdType="pmc">PMC8308514</ArticleId><ArticleId IdType="pubmed">34358031</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L., Zhang F., Ding X., Wu G., Lam Y. Y., Wang X., et al. (2018). Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 359 1151&#x2013;1156. 10.1126/science.aao5774</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aao5774</ArticleId><ArticleId IdType="pubmed">29590046</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong H., Wang Y., Shi Z., Zhang L., Ren H., He W., et al. (2021). Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients. Cell Discov. 7:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8043102</ArticleId><ArticleId IdType="pubmed">33850111</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong P., Xu J., Yang D., Shen Y., Wang L., Feng Y., et al. (2020). COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms. Signal Transduct. Target. Ther. 5:256. 10.1038/s41392-020-00373-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00373-7</ArticleId><ArticleId IdType="pmc">PMC7605138</ArticleId><ArticleId IdType="pubmed">33139693</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Li C., Liu X., Chiu M. C., Zhao X., Wang D., et al. (2020). Infection of bat and human intestinal organoids by SARS-CoV-2. Nat. Med. 26 1077&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">32405028</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Li C., Zhao G., Chu H., Wang D., Yan H. H., et al. (2017). Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus. Sci. Adv. 3:eaao4966. 10.1126/sciadv.aao4966</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aao4966</ArticleId><ArticleId IdType="pmc">PMC5687858</ArticleId><ArticleId IdType="pubmed">29152574</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., et al. (2020). A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382 727&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A., Koch R., Jukic A., Pfister A., Meyer M., R&#xf6;ssler A., et al. (2022). Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology 163 495&#x2013;506.e498. 10.1053/j.gastro.2022.04.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou X., Chen K., Zou J., Han P., Hao J., Han Z. (2020). Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front. Med. 14:185&#x2013;192. 10.1007/s11684-020-0754-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-020-0754-0</ArticleId><ArticleId IdType="pmc">PMC7088738</ArticleId><ArticleId IdType="pubmed">32170560</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Liu Q., Zhang F., Lui G. C., Tso E. Y., Yeoh Y. K., et al. (2021). Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut 70 276&#x2013;284. 10.1136/gutjnl-2020-322294</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-322294</ArticleId><ArticleId IdType="pmc">PMC7385744</ArticleId><ArticleId IdType="pubmed">32690600</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhang F., Lui G. C. Y., Yeoh Y. K., Li A. Y. L., Zhan H., et al. (2020b). Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology 159 944&#x2013;955.e948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhan H., Zhang F., Liu Q., Tso E. Y. K., Lui G. C. Y., et al. (2020a). Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge. Gastroenterology 159 1302&#x2013;1310.e1305. 10.1053/j.gastro.2020.06.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.06.048</ArticleId><ArticleId IdType="pmc">PMC7318920</ArticleId><ArticleId IdType="pubmed">32598884</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>